Dear congress visitors, it is an honor and pleasure to invite you to the PHARMAFORUM2025, which focuses on cutting-edge research in drug discovery, development, assessment, and innovation in clinical technology. There has been remarkable progress in this area, which is of fundamental and clinical relevance, as a result of combining a comprehensive approach to understanding the causes and treatments of disease with the application of modern molecular technologies.
Several topics of this progress will be covered at this meeting, such as: drug delivery and targeting; formulation design, engineering, and processing; pharmacokinetics, pharmacodynamics, and pharmacogenomics; pharmacognosy and phytochemistry; molecular biopharmaceutics and drug disposition; computational biopharmaceutics; pharmaceutical microbiology and biotechnology; and industrial pharmacy. Collective presentation and discussion of these and other pharmaceutical topics by highly qualified researchers in one time and place are certain to point the way for future developments and progress.
This conference provides opportunities for the delegates to share new ideas and application experiences face to face, to establish business or research relations and to find international partners for future collaboration. PHARMAFORUM2025 will take place at in Kuala Lumpur, Malaysia. While you are there, I sincerely hope that you take the opportunity to network, learn, share and collaborate with international experts, and explore the beautiful locations and form lifelong memories. Get the opportunity to learn from session speakers’ industry professionals. Sign up on our website to register and gain knowledge and industry-relevant skills. We are enthusiastic about your attendance and participation. Enjoy the conference!
Warm Regards
Dr. Luís Manuel Lopes Rodrigues da Silva
Co-chair of PHARMAFORUM2025
Beira Interior University, Portugal
International Institute of Medicine & Science
USA
Kunming Institute of Zoology
China
Beira Interior University
Portugal
Zurich University
Switzerland
University of Modena and Reggio Emilia
Italy
Queen Elizabeth Hospital
China
National Cancer Center Hospital East,
Clinical Research Support Office
Japan
Czech University of Life Sciences Prague
Czech Republic
National University of Singapore
Singapore
University of Medicine and Pharmacy "Grigore T. Popa"
Romania
Guizhou Medical University
China
University of Life Sciences "King Mihai I" from Timisoara
Romania
Ubon Ratchathani University
Thailand
Universitas Airlangga
Indonesia
University of Sharjah
United Arab Emirates
University of Jordan
Jordan
Ubon Ratchathani University
Thailand
National University of Science and Technology
Oman
Acropolis Institute of Pharmaceutical Education & Research
India
Beira Interior University
Portugal
Kunming Institute of Zoology
China
National University of Singapore
Singapore
University of Life Sciences "King Mihai I" from Timisoara
Romania
Temple University
USA
PharSafer Associates Ltd
United Kingdom
National University of Science and Technology
Oman
Universitas Airlangga
Indonesia
Cairo University
Egypt
University of Cape Town
South Africa
National Cancer Center Hospital East, Clinical Research Support Office
Japan
Bayer
México
Bulent Ecevit University
Turkey
JNV University
India
Shaqra Uinversity
Saudi Arabia